Cell line · CVCL_0332

Hs 578T

Cancer cell line, Homo sapiens. Invasive breast carcinoma of no special type. 156 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. Hs 578T. Cell lines, record CVCL_0332. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0332

On this page

Cell line

As Cellosaurus gives it.

Name: Hs 578T
Accession: CVCL_0332
RRID: RRID:CVCL_0332
Synonyms: HS 578T, Hs-578T, HS-578T, Hs_578t, Hs-578-T, HS-578-T, Hs 578.T, HS578T, Hs578T, Hs578t, HS0578T, 578T, HS578, Hs578, Homo sapiens No. 578, tumor cells
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 74Y
Category: Cancer cell line
Diseases: Invasive breast carcinoma of no special type (NCIt C4194)
Derived from: Breast (in situ)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers156

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

Paper	Journal	Year	How we know	Source
VCP-Regulated LMF2 Stabilizes the Cholesterol Biosynthesis Enzyme HMGCS1 to Drive Cancer Progression and Confer Capecitabine Resistance in Triple-Negative Breast Cancer.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
The role of autoproteolysis and mitoribosomal proteins in the regulation of the mitochondrial LACTB tumor suppressor.	EMBO Rep	2026	Its Methods give the RRID and name the line	PubMed
Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.	Cell Rep Med	2026	Its Methods give the RRID and name the line	PubMed
Role of orphan G protein-coupled receptor GPR52 in breast cancer cell multicellular organization and collective invasion.	Br J Cancer	2026	Its Methods give the RRID and name the line	PubMed
Intratumoral Hypoxia Triggers Mitochondrial BHLHE40 ROS Sensing Pathway to Promote Radioresistance in Triple-Negative Breast Cancer.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
ENO2 sustains cancer stemness and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis in triple-negative breast cancer.	Cell Death Dis	2026	Its Methods give the RRID and name the line	PubMed
Distinct metabolic dependency on BCAA defines cancer stemness and malignancy in human triple-negative breast cancer.	Cell Rep	2026	Its Methods give the RRID and name the line	PubMed
UBE2L6 promotes invasion and metastasis of triple-negative breast cancer by enhancing autophagy through STK38 ISGylation.	Cell Mol Life Sci	2026	Its Methods give the RRID and name the line	PubMed
Covalent Inhibition of SHMT2 by Gambogic Acid Induces Ferroptosis Through Mitochondrial Collapse in Triple-Negative Breast Cancer.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
Insulin-like growth factor 1 receptor regulates breast cancer cell adhesion through beta-1 integrin.	Front Endocrinol (Lausanne)	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 156

See all 156 papers

Relatives9

Relation	Cell line	Accession	Source
Derived from it	Hs 578T Hc5-1	CVCL_E8BS	Cell lines
Derived from it	Hs 578T Hc5-2	CVCL_E8BT	Cell lines
Derived from it	Hs 578T Hcg-11	CVCL_E8BU	Cell lines
Derived from it	Hs578T-Dox	CVCL_IR02	Cell lines
Derived from it	Hs578T-Luc	CVCL_J255	Cell lines
Derived from it	Hs578T-delta-hTfR1	CVCL_YL24	Cell lines
Derived from it	Hs578Ts(i)8	CVCL_M363	Cell lines
From the same person	Hs 578.Mg	CVCL_S253	Cell lines
From the same person	Hs 578Bst	CVCL_0807	Cell lines

Cell banks12

Cell bank	Catalog number	Status	Source
ATCC	CRL-7849	Discontinued	Cellosaurus
ATCC	HTB-126		ATCC
BCRC	60120		BCRC
CCTCC	GDC0252		Cellosaurus
CLS	305089		CLS
DSMZ	ACC-781		DSMZ
ECACC	86082104		ECACC
IBRC	C10150		Cellosaurus
ICLC	HTL00007		ICLC
KCB	KCB 2012025YJ		Cellosaurus

1 to 10 of 12

See all 12 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0332

GET https://conductscience.org/api/cell-lines/v1/CVCL_0332/papers?page=2

API reference For AI assistants